Covered recipient · General Payments record
RISHI K BALA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,588.84
- Reported across 233 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $644.29 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $204.71 | 6 |
| Bioventus LLC | $184.10 | 3 |
| GlaxoSmithKline, LLC. | $121.85 | 1 |
| Exact Sciences Corporation | $39.50 | 2 |
| Inspire Medical Systems, Inc. | $35.63 | 1 |
| GE HEALTHCARE | $24.12 | 1 |
| DEXCOM, INC. | $20.78 | 1 |
| Fortis Surgical, LLC | $13.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.52 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125028386 | CMS |
| Abbott Laboratories | $15.94 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125028390 | CMS |
| Abbott Laboratories | $17.31 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125028398 | CMS |
| Abbott Laboratories | $19.83 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125028406 | CMS |
| Abbott Laboratories | $118.48 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125028411 | CMS |
| Abbott Laboratories | $16.63 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125028415 | CMS |
| Bioventus LLC | $25.52 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137436357 | CMS |
| Bioventus LLC | $121.57 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137436359 | CMS |
| Bioventus LLC | $37.01 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137436361 | CMS |
| Dexcom, Inc. | $20.78 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331097 | CMS |
| Exact Sciences Corporation | $19.65 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114583943 | CMS |
| Exact Sciences Corporation | $19.85 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114583947 | CMS |
| Fortis Surgical, LLC | $13.60 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119753899 | CMS |
| GE HEALTHCARE | $24.12 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144681640 | CMS |
| GlaxoSmithKline, LLC. | $121.85 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116312149 | CMS |
| Inspire Medical Systems, Inc. | $35.63 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148041726 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.